Disclosure 0001902368-26-000008-1

SEC FORM 4

$289,287.35

Travere Therapeutics, Inc. (TVTX)

Acquisition (code M) of 32,395 shares at $8.93 per share.

Reporting Person Inrig Jula · Officer Title EVP, Head of R&D & CMO · Transaction Code M

Traded Sep 15, 2026 · Disclosed Sep 17, 2026

Source: SEC Form 4 · 0001902368-26-000008 · filed 2026-09-17 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Travere Therapeutics, Inc. (TVTX)." Disclosed 2026-09-17. https://desqlong.com/cards/0001902368-26-000008-1 (retrieved 2026-09-26).